Aurrigo's 160% Surge, Oxford Drug Design Funding, Fossil-Free Fuel at National Oceanography Centre

The Business Magazine Newscast

These are the top stories making the headlines across The Business Magazine website today:

Aurrigo International sees strong growth in autonomous division in first half

Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.

Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/

Oxford Drug Design set to help advance new treatments for CF lung infections

Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.

Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/

Southampton’s National Oceanography Centre trials low-carbon fuel

On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.

Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/